Ryan Cole insider trades
Open-market stock purchases and sales by Ryan Cole, Chief Operating Officer at Aurinia Pharmaceuticals Inc, from SEC Form 4 filings since May 18, 2026.
Companies traded
- AUPH Aurinia Pharmaceuticals Inc: other filings, last May 18, 2026